Greenwood Genetic Center is on the verge of a historic partnership with The Medical University of South Carolina that the institution hopes will help it thrive.
Greenwood Genetic Center researchers are reporting the discovery of a mechanism that contributes to the tissue phenotypes seen in PMM2-CDG, the most common of the congenital disorders of glycosylation (CDGs).